Literature DB >> 10729121

Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.

H Katano1, T Iwasaki, N Baba, M Terai, S Mori, A Iwamoto, T Kurata, T Sata.   

Abstract

To establish a sensitive and specific antibody assay, potent antigenic proteins encoded by human herpesvirus 8 (HHV8) were studied. Fifteen recombinant HHV8-encoded proteins were produced as glutathione S-transferase fusion proteins. The sera from AIDS-associated Kaposi's sarcoma (KS) patients reacted with four proteins encoded by open reading frames (ORFs) K8.1, 59, 65, and 73 in a Western blot assay. An enzyme-linked immunosorbent assay (ELISA) using these four proteins as antigens (mixed-antigen ELISA) revealed that all 26 sera derived from KS patients (24 with and 2 without human immunodeficiency virus infection) became positive for anti-HHV8 antibodies. The presence of HHV8 was demonstrated in 14 (1. 4%) of 1,004 sera from the Japanese general population and 10 (1.9%) of 527 sera from patients without HHV8-associated diseases. The presence of immunoglobulin G (IgG) and IgM antibodies against HHV8 examined further by the mixed-antigen ELISA and Western blotting revealed IgG antibody in all ELISA-positive sera, while IgM antibody against ORF K8.1 was absent. These data suggest that the ORF 73 and 65 proteins are potent antigens for a sensitive serological assay.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729121      PMCID: PMC111855          DOI: 10.1128/jvi.74.8.3478-3485.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; D R Hoover; T J Spira; C R Rinaldo; A Saah; J Phair; R Detels; P Parry; Y Chang; P S Moore
Journal:  N Engl J Med       Date:  1996-07-25       Impact factor: 91.245

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.

Authors:  S F Lin; R Sun; L Heston; L Gradoville; D Shedd; K Haglund; M Rigsby; G Miller
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.

Authors:  D H Kedes; D Ganem; N Ameli; P Bacchetti; R Greenblatt
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

7.  Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.

Authors:  S André; O Schatz; J R Bogner; H Zeichhardt; M Stöffler-Meilicke; H U Jahn; R Ullrich; A K Sonntag; R Kehm; J Haas
Journal:  J Mol Med (Berl)       Date:  1997-02       Impact factor: 4.599

8.  Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.

Authors:  D A Davis; R W Humphrey; F M Newcomb; T R O'Brien; J J Goedert; S E Straus; R Yarchoan
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

9.  Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.

Authors:  B Chandran; M S Smith; D M Koelle; L Corey; R Horvat; E Goldstein
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

10.  Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.

Authors:  C P Pau; L L Lam; T J Spira; J B Black; J A Stewart; P E Pellett; R A Respess
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more
  22 in total

Review 1.  Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems.

Authors:  Peter D Burbelo; Kathryn H Ching; Kathleen E Bren; Michael J Iadarola
Journal:  Expert Rev Proteomics       Date:  2011-06       Impact factor: 3.940

2.  Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1.

Authors:  Lee L Lam; Chou-Pong Pau; Sheila C Dollard; Philip E Pellett; Thomas J Spira
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission.

Authors:  S Sakurada; H Katano; T Sata; H Ohkuni; T Watanabe; S Mori
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.

Authors:  Eriko Ohsaki; Keiji Ueda; Shuhei Sakakibara; Eunju Do; Kaori Yada; Koichi Yamanishi
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.

Authors:  Daisuke Kaji; Yasunori Ota; Yasuharu Sato; Koji Nagafuji; Yasunori Ueda; Masataka Okamoto; Yasushi Terasaki; Naoko Tsuyama; Kosei Matsue; Tomohiro Kinoshita; Go Yamamoto; Shuichi Taniguchi; Shigeru Chiba; Koichi Ohshima; Koji Izutsu
Journal:  Blood Adv       Date:  2020-09-22

Review 6.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

7.  Human herpesvirus 8 (HHV8) sequence variations in HHV8 related tumours in Okinawa, a subtropical island in southern Japan.

Authors:  K Kamiyama; T Kinjo; K Chinen; T Iwamasa; H Uezato; J-I Miyagi; N Mori; N Yamane
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Development of whole-virus multiplex luminex-based serological assays for diagnosis of infections with kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 homologs in macaques.

Authors:  Jonathan T Ryan; Timothy M Rose
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

Review 9.  Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Authors:  Lorin Begré; Eliane Rohner; Sam M Mbulaiteye; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2016-04-26       Impact factor: 7.396

10.  Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.

Authors:  Hiroki Goto; Yuki Kojima; Hirokazu Nagai; Seiji Okada
Journal:  Int J Hematol       Date:  2013-04-21       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.